ARTICLE | Company News
Pilot Therapeutics Inc., Bristol-Myers deal
October 22, 2001 7:00 AM UTC
BMY granted ILRG an exclusive worldwide license to develop and market a class of oral retinoids, which ILRG will develop initially to treat acne. ILRG said it will develop products through Phase IIa s...